Siirry suoraan sisältöön
Antibody-Drug Conjugates
Tallenna

Antibody-Drug Conjugates

Case studies are presented for the three ADCs that have received FDA approval: gemtuzumab ozogamicin (Mylotarg®), Brentuximab vedotin (Adcetris®), and ado-trastuzumab emtansine (Kadcyla®), as well as an ADC in late-stage clinical trials, glembatumumab vedotin (CDX-011).
Alaotsikko
The 21st Century Magic Bullets for Cancer
Painos
Softcover reprint of the original 1st ed. 2015
ISBN
9783319376691
Kieli
englanti
Paino
310 grammaa
Julkaisupäivä
6.10.2016
Sivumäärä
252